tiprankstipranks
Munich Reinsurance Company (DE:MUV2)
XETRA:MUV2
Germany Market
Want to see DE:MUV2 full AI Analyst Report?

Munich Reinsurance (MUV2) Earnings Dates, Call Summary & Reports

203 Followers

Earnings Data

Report Date
May 12, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
13.76
Last Year’s EPS
8.32
Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a largely positive strategic and financial story: strong profitability (EUR 6.1bn net earnings), high ROE (~18%), robust solvency (~298%), meaningful shareholder distributions (20% dividend increase and EUR 2.25bn buybacks), and solid segment performances (GSI, Life & Health Re, ERGO). Headline strengths are tempered by top-line pressure (revenue missed guidance by ~EUR 3bn), renewal-driven volume declines (~-7.8%) and deliberate near-term reserve and disposal actions that reduced immediacy of some earnings. On balance the company emphasizes disciplined underwriting, conservative reserving and long-term capital deployment, with management framing short-term hits as intentional investments in resilience and future returns.
Company Guidance
Munich Re reiterated concrete 2026 guidance and capital plans: group net income is projected at about EUR 6.3 billion (after FY‑2025 net earnings of EUR 6.1 billion), with a reinsurance business‑field revenue ambition of ~EUR 40 billion; the Solvency II ratio remains very strong (c.298% at year‑end 2025, “well above 200%” going forward), HGB distributable earnings exceed EUR 10 billion, and management expects an EPS CAGR of >8% and an ROE above 18% as Ambition 2030 starts. Capital returns stay generous — dividend per share up 20% to EUR 24 and share buybacks of EUR 2.25 billion (together returning almost 90% of earnings; stated payout intent >80%, this year ~87%) — while segment and performance targets include GSI organic CAGR 5–9%, Life & Health Re growth 8–12% (total technical result expected to rise >10% to EUR 1.9bn), a group ROI of ~3.2% for 2025 (Q4 2.8%) with active management contributing >30 bps, reinvestment yield ~3.8% (running yield in P&C ~4.1%), P&C Re headline combined ratio 73.5% (normalized ~80.1%; reserve releases 5.0% FY, 1.8% in Q4), GSI combined ratio 85.9% and ERGO combined ratio ~89%.
Record Net Earnings and EPS Growth
Net earnings rose almost 8% year-on-year to EUR 6.1 billion for FY2025, exceeding the EUR 6.0 billion target and supporting continued EPS growth (management expects an EPS CAGR of >8% going forward).
Strong Return on Equity and Capital Strength
Return on equity increased to 18.3% (end of Ambition 2025) and the Solvency II ratio stood at ~298% (almost 300%), indicating very comfortable capitalization and strategic flexibility.
Substantial Shareholder Returns
Dividend per share proposed up 20% to EUR 24; share buybacks increased to EUR 2.25 billion; combined capital return equals almost 90% of earnings, with a stated intention to pay out >80% of IFRS net earnings going forward.
P&C Reinsurance Headline Profitability
P&C reinsurance headline combined ratio improved to an all-time low of 73.5% for the year (benefiting from benign major losses), with a normalized combined ratio around 80.1% (≈1 percentage point above prior guidance after prudence measures).
Global Specialty Insurance (GSI) Outperformance
GSI delivered an excellent full-year combined ratio of 85.9% and contributed ~EUR 560 million in net income; management targets organic CAGR of 5%–9% for GSI through Ambition 2030.
Life & Health Reinsurance Momentum and CSM Growth
Life & Health Re achieved a total technical result of EUR 1.7 billion (met guidance); contractual service margin (CSM) rose to above EUR 15 billion (≈+40% since end-2022) and management expects total technical result to increase >10% to EUR 1.9 billion next year.
ERGO Delivered on Targets and International Growth
ERGO met guidance with strong net earnings, achieved a P&C combined ratio of ~89% in targeted areas (improvements in motor) and saw international operations grow to ~30% of revenue, aided by the NEXT Insurance acquisition.
Investment Income and Active Management Contribution
Full-year return on investment was 3.2% (above the ≥3% target); Q4 ROI 2.8%; active management added >30 basis points to group ROI; reinvestment yield ~3.8% after deliberate portfolio repositioning (including EUR 0.8 billion of disposal losses to shift into higher-yield assets).
Strong HGB Result and Distributable Earnings
HGB (German GAAP) result improved to EUR 5.5 billion and the stock of distributable earnings exceeds EUR 10 billion, providing a solid base for future distributions.

Munich Reinsurance (DE:MUV2) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:MUV2 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 12, 2026
2026 (Q1)
13.76 / -
8.32
Feb 26, 2026
2025 (Q4)
7.21 / 7.36
7.377-0.23% (-0.02)
Nov 11, 2025
2025 (Q3)
14.51 / 15.46
7.02120.17% (+8.44)
Aug 08, 2025
2025 (Q2)
13.29 / 15.94
12.1631.09% (+3.78)
May 13, 2025
2025 (Q1)
8.14 / 8.32
15.965-47.89% (-7.64)
Feb 26, 2025
2024 (Q4)
5.70 / 7.38
7.455-1.05% (-0.08)
Nov 07, 2024
2024 (Q3)
8.59 / 7.02
8.61-18.47% (-1.59)
Aug 08, 2024
2024 (Q2)
10.98 / 12.16
8.4543.91% (+3.71)
May 08, 2024
2024 (Q1)
12.11 / 15.96
9.19573.63% (+6.77)
Feb 27, 2024
2023 (Q4)
7.22 / 7.46
11.05-32.53% (-3.60)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:MUV2 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
€527.41€523.60-0.72%
Nov 11, 2025
€519.59€520.54+0.18%
Aug 08, 2025
€580.10€538.29-7.21%
May 13, 2025
€554.33€529.13-4.55%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Munich Reinsurance Company (DE:MUV2) report earnings?
Munich Reinsurance Company (DE:MUV2) is schdueled to report earning on May 12, 2026, Before Open (Confirmed).
    What is Munich Reinsurance Company (DE:MUV2) earnings time?
    Munich Reinsurance Company (DE:MUV2) earnings time is at May 12, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Munich Reinsurance Company stock?
          The P/E ratio of Munich Reinsurance is N/A.
            What is DE:MUV2 EPS forecast?
            DE:MUV2 EPS forecast for the fiscal quarter 2026 (Q1) is 13.76.